Telecobalt therapy for prostatic cancer

rationale, results and future considerations

M. McLoughlin, T. Hazra, Horst K.A. Schirmer, W. W. Scott

Research output: Contribution to journalArticle

Abstract

External supervoltage radiation is now an accepted form of treatment for adenocarcinoma of the prostate, but the tumor response cannot be predicted. It is hoped that accurate clinical staging coupled with a biological staging of the tumor cells with catalase activity will enable one to predict this response. Ionizing radiations act by producing active radicals, hence the rationale of studying the tissue catalase activity in conjunction with the histological grading may provide a more accurate index of patients who would gain the most benefit from radiotherapy.

Original languageEnglish (US)
Pages (from-to)378-379
Number of pages2
JournalJournal of Urology
Volume113
Issue number3
StatePublished - 1975

Fingerprint

Catalase
Prostatic Neoplasms
Neoplasm Staging
Ionizing Radiation
Prostate
Adenocarcinoma
Radiotherapy
Radiation
Therapeutics
Neoplasms

ASJC Scopus subject areas

  • Urology

Cite this

Telecobalt therapy for prostatic cancer : rationale, results and future considerations. / McLoughlin, M.; Hazra, T.; Schirmer, Horst K.A.; Scott, W. W.

In: Journal of Urology, Vol. 113, No. 3, 1975, p. 378-379.

Research output: Contribution to journalArticle

McLoughlin, M. ; Hazra, T. ; Schirmer, Horst K.A. ; Scott, W. W. / Telecobalt therapy for prostatic cancer : rationale, results and future considerations. In: Journal of Urology. 1975 ; Vol. 113, No. 3. pp. 378-379.
@article{c3a5b62cf58946be90786ba6193dfb3d,
title = "Telecobalt therapy for prostatic cancer: rationale, results and future considerations",
abstract = "External supervoltage radiation is now an accepted form of treatment for adenocarcinoma of the prostate, but the tumor response cannot be predicted. It is hoped that accurate clinical staging coupled with a biological staging of the tumor cells with catalase activity will enable one to predict this response. Ionizing radiations act by producing active radicals, hence the rationale of studying the tissue catalase activity in conjunction with the histological grading may provide a more accurate index of patients who would gain the most benefit from radiotherapy.",
author = "M. McLoughlin and T. Hazra and Schirmer, {Horst K.A.} and Scott, {W. W.}",
year = "1975",
language = "English (US)",
volume = "113",
pages = "378--379",
journal = "Journal of Urology",
issn = "0022-5347",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Telecobalt therapy for prostatic cancer

T2 - rationale, results and future considerations

AU - McLoughlin, M.

AU - Hazra, T.

AU - Schirmer, Horst K.A.

AU - Scott, W. W.

PY - 1975

Y1 - 1975

N2 - External supervoltage radiation is now an accepted form of treatment for adenocarcinoma of the prostate, but the tumor response cannot be predicted. It is hoped that accurate clinical staging coupled with a biological staging of the tumor cells with catalase activity will enable one to predict this response. Ionizing radiations act by producing active radicals, hence the rationale of studying the tissue catalase activity in conjunction with the histological grading may provide a more accurate index of patients who would gain the most benefit from radiotherapy.

AB - External supervoltage radiation is now an accepted form of treatment for adenocarcinoma of the prostate, but the tumor response cannot be predicted. It is hoped that accurate clinical staging coupled with a biological staging of the tumor cells with catalase activity will enable one to predict this response. Ionizing radiations act by producing active radicals, hence the rationale of studying the tissue catalase activity in conjunction with the histological grading may provide a more accurate index of patients who would gain the most benefit from radiotherapy.

UR - http://www.scopus.com/inward/record.url?scp=0016639720&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0016639720&partnerID=8YFLogxK

M3 - Article

VL - 113

SP - 378

EP - 379

JO - Journal of Urology

JF - Journal of Urology

SN - 0022-5347

IS - 3

ER -